Obesity & metabolic patent intelligence

US 10537528

Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine compounds

The Regents of the University of California · Granted Tue Jan 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10537537

Methods of treatment of inflammation related conditions using pluripotent anti-inflammatory and metabolic modulators

INSTITUT PASTEUR DE MONTEVIDEO · Granted Tue Jan 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10507284

Daily periodic target-zone modulation in the model predictive control problem for artificial pancreas for type I diabetes applications

The Regents of the University of California · Granted Tue Dec 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10500271

Compositions and methods for self-adjuvanting vaccines against microbes and tumors

The Regents of the University of California · Granted Tue Dec 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10449171

Compositions and methods for diagnosis and treatment of metabolic syndrome

The United States of America, as represented by Secretary of the Navy · Granted Tue Oct 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10449170

Compositions for diagnosis and treatment of type 2 diabetes

The United States of America, as represented by Secretary of the Navy · Granted Tue Oct 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10442856

Methods of treating obesity with anti-ANGPTL8 antibodies

REGENERON PHARMACEUTICALS, INC. · Granted Tue Oct 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10434078

GABA agonists in the treatment of disorders associated with metabolic syndrome and GABA combinations in treatment or prophylaxis of type I diabetes

The Regents of the University of California · Granted Tue Oct 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10413577

Compositions and methods for promoting growth of beneficial microbes to treat or prevent disease or prolong life

The Regents of the University of California · Granted Tue Sep 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10398762

Methods and compositions for treating diabetes

Oramed Ltd. · Granted Tue Sep 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10351598

Peptide with anti-obesity and anti-diabetic efficacy and use thereof

CAREGEN CO., LTD. · Granted Tue Jul 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10351597

Peptide with anti-obesity and anti-diabetes activity and use thereof

CAREGEN CO., LTD. · Granted Tue Jul 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10329298

Inhibitors of cellular metabolic processes

Agios Pharmaceuticals, Inc. · Granted Tue Jun 25 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 20 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10314885

Oxytocin treatment to modify blood glucose and treat metabolic disease

The Regents of the University of California · Granted Tue Jun 11 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10307428

Therapeutic compositions for diabetic symmetrical polyneuropathy

The Regents of the University of California · Granted Tue Jun 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10307386

Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine products

The Regents of the University of California · Granted Tue Jun 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10300095

AAV mediated exendin-4 gene transfer to salivary glands to protect subjects from diabetes or obesity

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue May 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10287297

Epoxyazulene derivatives useful for treating cancer and diabetes

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 14 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10265394

Compositions and methods for self-adjuvanting vaccines against microbes and tumors

The Regents of the University of California · Granted Tue Apr 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10245255

Compositions and methods for the treatment of obesity and related disorders

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Apr 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10238734

Compositions and methods for self-adjuvanting vaccines against microbes and tumors

The Regents of the University of California · Granted Tue Mar 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10202618

Method of treating type I diabetes using an AAV vector encoding uracortin 2

The Regents of the University of California · Granted Tue Feb 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10196613

Stem cells for modeling type 2 diabetes

REGENERON PHARMACEUTICALS, INC. · Granted Tue Feb 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10196612

Method of characterizing and manipulating adipose stem cell depots to a metabolically healthy state

The United States of America as Represented by the Department of Veterens Affairs · Granted Tue Feb 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10155003

Methods and compositions comprising ursolic acid and/or resveratrol for treating diabetes, or cancer

The Board of Regents of the University of Texas System · Granted Tue Dec 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10155798

Anti-obesity compounds derived from neuromedin U

The Regents of the University of California · Granted Tue Dec 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10149847

Oxabicycloheptanes and oxabicycloheptenes for the treatment of diabetes

Lixte Biotechnology, Inc. · Granted Tue Dec 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10130080

Obesity animal model and methods for making and using thereof

PERFECT (CHINA) CO., LTD. · Granted Tue Nov 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10105341

Treatment for obesity

Jazz Pharmaceuticals International III Limited · Granted Tue Oct 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10098971

Library of pH responsive polymers and nanoprobes thereof

The Board of Regents of the University of Texas System · Granted Tue Oct 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10077446

Glucan-encapsulated siRNA for treating type 2 diabetes mellitus

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Sep 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10052362

Glial cell line derived neurotrophic factor, obesity, and obesity-related diseases and conditions

The United States Geovernment represented by the United States Department of Veterans Affairs · Granted Tue Aug 21 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10040769

HDAC inhibitors for the treatment of diabetic peripheral neuropathy

Regenacy Pharmaceuticals, Inc. · Granted Tue Aug 07 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 02 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10028983

Compositions and methods for promoting growth of beneficial microbes to treat or prevent disease or prolong life

The Regents of the University of California · Granted Tue Jul 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10022347

Compositions and methods for diagnosis and treatment of metabolic syndrome

United States of America as represented by the Secretary of the Air Force · Granted Tue Jul 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10010571

Nutritional supplement for the enhancement of muscle irisin and enhancement of brown fat, metabolic rate, and weight loss, and methods of use thereof

Maximum Human Performance, LLC · Granted Tue Jul 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10004782

Glucokinase activator compositions for the treatment of diabetes

VTV THERAPEUTICS LLC · Granted Tue Jun 26 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9993481

Methods and compositions for the treatment of metabolic disorders

BIOMARIN PHARMACEUTICAL INC. · Granted Tue Jun 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9988447

Treatment of diabetes

XBIOTECH INC. · Granted Tue Jun 05 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 31 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9987253

Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

Jenrin Discovery, LLC · Granted Tue Jun 05 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 31 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9909124

Compounds and methods for modulating apolipoprotein C-III expression for improving a diabetic profile

Ionis Pharmaceuticals, Inc. · Granted Tue Mar 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9878010

Methods of treating metabolic disorders

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jan 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9878006

Treatment of obesity and obesity related disorders by pharmalogical targeting of Kv1.3 potassium channels

The Regents of the University of California · Granted Tue Jan 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9820955

GABA agonists in the treatment of disorders associated with metabolic syndrome and GABA combinations in treatment or prophylaxis of type I diabetes

The Regents of the University of California · Granted Tue Nov 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9764001

Target for diagnosis and treatment of diabetes and cardiovascular diseases

The Regents of the University of California · Granted Tue Sep 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9757407

Treatment of viral infections by modulation of host cell metabolic pathways

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Sep 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9750705

Agents useful for treating obesity, diabetes and related disorders

The Regents of the University of California · Granted Tue Sep 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9713600

Method for treating metabolic syndrome

United States of America as represented by the Secretary of the Air Force · Granted Tue Jul 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)